And we're off

ACT ONE, SCENE ONE...

I hope you’ll bear with me.

This newsletter will start with a focus on Covid, as you might expect given my Twitter feed. I want to offer an update on what we now know about the vaccines, for example. The topic is too long to tweet properly, but I don’t have time to write a full booklet about it. A newsletter seems like a good alternative.

But over the nex…